Vimarsana.com

Latest Breaking News On - Vest asset management - Page 1 : comparemela.com

Teva Pharmaceutical Industries (NYSE:TEVA) Hits New 12-Month High at $17.54

Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) hit a new 52-week high on Tuesday . The company traded as high as $17.54 and last traded at $17.51, with a volume of 6441192 shares changing hands. The stock had previously closed at $16.85. Wall Street Analyst Weigh In TEVA has been the topic of […]

United-states
Israel
America
Amir-weiss
Piper-sandler
Vikkil-conway
Dekabank-deutsche-girozentrale
Jpmorgan-chase-co
Clarivest-asset-management
News-ratings-for-teva-pharmaceutical-industries-daily
Teva-pharmaceutical-industries-limited
Teva-pharmaceutical-industries

Fund 1 Investments LLC Has $2.92 Million Stake in PetIQ, Inc. (NASDAQ:PETQ)

Fund 1 Investments LLC lowered its position in PetIQ, Inc. (NASDAQ:PETQ – Free Report) by 11.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 147,645 shares of the company’s stock after selling 18,355 shares during the period. PetIQ accounts for 0.3% of Fund 1 Investments […]

Switzerland
United-states
Swiss
Clarivest-asset-management
Swiss-national-bank
Petiq-inc
Jefferies-financial-group
Dimensional-fund-advisors
Nasdaq
Vanguard-group-inc
Free-report

Cyrus Harmon Sells 5,000 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Stock

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) Director Cyrus Harmon sold 5,000 shares of the business’s stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $10.93, for a total value of $54,650.00. Following the completion of the transaction, the director now owns 786,283 shares […]

Cyrus-harmon
Clarivest-asset-management
Silverarc-capital-management
Goldman-sachs-group
Olema-pharmaceuticals
Quarter-for-olema-pharmaceuticals
Victory-capital-management-inc
News-ratings-for-olema-pharmaceuticals-daily
Nasdaq
Vivo-capital
Olema-pharmaceuticals-inc
Institutional-investors-weigh-in-on-olema-pharmaceuticals

Short Interest in Holley Inc. (NYSE:HLLY) Rises By 10.4%

Holley Inc. (NYSE:HLLY – Get Free Report) saw a significant growth in short interest during the month of May. As of May 15th, there was short interest totalling 2,550,000 shares, a growth of 10.4% from the April 30th total of 2,310,000 shares. Based on an average daily trading volume, of 285,500 shares, the days-to-cover ratio […]

Bamco
Xizang
China
United-states
Canada
Graham-clempson
Jpmorgan-chase-co
Clarivest-asset-management
Norden-group
Telsey-advisory-group
Holley-inc
Securities-exchange-commission

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Sees Large Decline in Short Interest

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) was the target of a significant decrease in short interest during the month of May. As of May 15th, there was short interest totalling 204,400 shares, a decrease of 11.1% from the April 30th total of 229,900 shares. Based on an average daily volume of 159,600 shares, […]

Great-lakes
Canada-general
Canada
United-states
Jamesg-marken
Skandinaviska-enskilda-banken
Stephenp-carey
Nasdaq
Pharmaceuticals-daily
Ani-pharmaceuticals-inc
Global-alpha-capital-management-ltd
Clarivest-asset-management

vimarsana © 2020. All Rights Reserved.